Catherine Tribouley Selected Research

Catherine Tribouley Research Topics

2	Neoplasms (Cancer) 01/2022 - 10/2018
2	Asthma (Bronchial Asthma) 01/2016 - 08/2013
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2018
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2015
1	Contact Dermatitis (Eczema, Contact) 02/2014
1	Arthritis (Polyarthritis) 02/2014
1	Experimental Arthritis 02/2014
1	Pneumonia (Pneumonitis) 08/2013
1	Inflammation (Inflammations) 08/2013

2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
1	budigalimabIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	LigandsIBA 01/2022
1	Macrophage Colony-Stimulating FactorIBA 01/2022
1	Surface Antigens (Surface Antigen)IBA 10/2018
1	Proteins (Proteins, Gene)FDA Link 10/2018
1	AntigensIBA 10/2018
1	AllergensIBA 01/2016
1	Imatinib Mesylate (Gleevec)FDA Link 04/2015
1	nilotinib FDA Link 04/2015
1	Tyrosine Kinase InhibitorsIBA 04/2015
1	5- fluoro- 2- (2- (1- (4- fluorophenyl)- 5- hydroxy- 4a- methyl- 1,4,4a,5,6,7- hexahydrocyclopenta(f)indazol- 5- yl)ethyl)benzamideIBA 02/2014
1	Glucose (Dextrose)FDA LinkGeneric 02/2014
1	Insulin (Novolin)FDA Link 02/2014
1	Methylprednisolone FDA LinkGeneric 02/2014
1	CytokinesIBA 08/2013
1	Thymic Stromal LymphopoietinIBA 08/2013

1	Therapeutics 10/2018